BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34231252)

  • 21. Concordance of HIV type 1 tropism phenotype to predictions using web-based analysis of V3 sequences: composite algorithms may be needed to properly assess viral tropism.
    Cabral GB; Ferreira JL; Coelho LP; Fonsi M; Estevam DL; Cavalcanti JS; Brígido LF
    AIDS Res Hum Retroviruses; 2012 Jul; 28(7):734-8. PubMed ID: 21919801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
    Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
    Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.
    Flynn JK; Paukovics G; Moore MS; Ellett A; Gray LR; Duncan R; Salimi H; Jubb B; Westby M; Purcell DF; Lewin SR; Lee B; Churchill MJ; Gorry PR; Roche M
    Virology; 2013 Jul; 442(1):51-8. PubMed ID: 23602007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application progress of CRISPR/Cas9 genome editing technology in the treatment of HIV-1 infection].
    Han Y; Li QW
    Yi Chuan; 2016 Jan; 38(1):9-16. PubMed ID: 26787519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Act now on CRISPR babies.
    Nature; 2019 Jun; 570(7760):137. PubMed ID: 31186572
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Kaufmann GR; Cunningham PH; Smith D; Grey P; Suzuki K; Carr A; Goh LE; Cooper DA
    J Infect Dis; 2001 Mar; 183(5):736-43. PubMed ID: 11181150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4
    Liu Z; Chen S; Jin X; Wang Q; Yang K; Li C; Xiao Q; Hou P; Liu S; Wu S; Hou W; Xiong Y; Kong C; Zhao X; Wu L; Li C; Sun G; Guo D
    Cell Biosci; 2017; 7():47. PubMed ID: 28904745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation of macrophage tropism among HIV-1 R5 envelopes in brain and other tissues.
    Peters PJ; Dueñas-Decamp MJ; Sullivan WM; Clapham PR
    J Neuroimmune Pharmacol; 2007 Mar; 2(1):32-41. PubMed ID: 18040824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc-finger nucleases make the cut in HIV.
    Owens B
    Nat Rev Drug Discov; 2014 May; 13(5):321-2. PubMed ID: 24781537
    [No Abstract]   [Full Text] [Related]  

  • 31. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
    Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure.
    June CH
    N Engl J Med; 2019 Sep; 381(13):1281-1283. PubMed ID: 31509669
    [No Abstract]   [Full Text] [Related]  

  • 33. Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4(+) T-cell lines determined by the capacity to exploit low concentrations of CCR5.
    Dejucq N; Simmons G; Clapham PR
    J Virol; 1999 Sep; 73(9):7842-7. PubMed ID: 10438877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Russian biologist plans more CRISPR-edited babies.
    Cyranoski D
    Nature; 2019 Jun; 570(7760):145-146. PubMed ID: 31186565
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function.
    Dejucq N
    J Leukoc Biol; 2000 Sep; 68(3):331-7. PubMed ID: 10985248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of viral coreceptors and enhanced macrophage tropism in human immunodeficiency virus type 1 disease progression.
    Gorry PR; Sterjovski J; Churchill M; Witlox K; Gray L; Cunningham A; Wesselingh S
    Sex Health; 2004; 1(1):23-34. PubMed ID: 16335478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatic analysis of neurotropic HIV envelope sequences identifies polymorphisms in the gp120 bridging sheet that increase macrophage-tropism through enhanced interactions with CCR5.
    Mefford ME; Kunstman K; Wolinsky SM; Gabuzda D
    Virology; 2015 Jul; 481():210-22. PubMed ID: 25797607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV type 1 coreceptor tropism, CCR5 genotype, and integrase inhibitor resistance profiles in Vietnam: implications for the introduction of new antiretroviral regimens.
    Luu QP; Dean J; Do TT; Carr MJ; Dunford L; Coughlan S; Connell J; Nguyen HT; Hall WW; Nguyen Thi LA
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1344-8. PubMed ID: 22264071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection.
    Liberatore RA; Mastrocola EJ; Cassella E; Schmidt F; Willen JR; Voronin D; Zang TM; Hatziioannou T; Bieniasz PD
    Elife; 2019 Oct; 8():. PubMed ID: 31644426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.